Dibazole
-
Dibazole
structure -
-
CAS No:
621-72-7
-
Formula:
C14H12N2
-
Chemical Name:
Dibazole
-
Synonyms:
1H-Benzimidazole,2-(phenylmethyl)-;Benzimidazole,2-benzyl-;2-(Phenylmethyl)-1H-benzimidazole;Bendazol;2-Benzylbenzimidazole;Dibasol;Dibazol;Dibazole;Tromasedan;Bendazole;NSC 60020;NSC 631632;2-Benzyl-1H-benzimidazole;2-Benzyl-1H-benzo[d]imidazole;2-Benzyl-1H-1,3-benzodiazole;2-Benzyl-1H-benzoimidazole;102389-81-1
-
Categories:
Active Pharmaceutical Ingredients > Circulatory System Drugs
-
CAS No:
Description
Bendazol is a hypotensive drug which can also enhance NO synthase activity in renal glomeruli and collecting tubules.
Bendazol is a member of benzimidazoles.
Characteristics
28.7
3.2
White or almost white crystalline powder
1.14 g/cm3 @ Temp: 298.15 °C
187 °C
453.5ºC at 760 mmHg
252.1±9.3 °C
1.680
>31.2 [ug/mL]
Oral-Mouse LD50: 100 mg/kg; Abdominal cavity-mouse LD50: 240 mg/kg
Flammable; burning produces toxic nitrogen oxide fumes
Safety Information
IRRITANT
Ventilated, low temperature and dry; stored separately from food materials in warehouse
P261, P264, P270, P271, P280, P301+P310, P302+P352, P304+P340, P305+P351+P338, P312, P321, P330, P332+P313, P337+P313, P362, P403+P233, P405, P501
H301
|Danger|H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]|P261, P264, P270, P271, P280, P301+P310, P302+P352, P304+P340, P305+P351+P338, P312, P321, P330, P332+P313, P337+P313, P362, P403+P233, P405, and P501|Aggregated GHS information provided by 38 companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Drug Information
Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (See all compounds classified as Adjuvants, Immunologic.)|Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)|Agents that promote the production and release of interferons. They include mitogens, lipopolysaccharides, and the synthetic polymers Poly A-U and Poly I-C. Viruses, bacteria, and protozoa have been also known to induce interferons. (See all compounds classified as Interferon Inducers.)|A heterogeneous group of drugs used to produce muscle relaxation, excepting the neuromuscular blocking agents. They have their primary clinical and therapeutic uses in the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. They have been used also for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in MULTIPLE SCLEROSIS. (From Smith and Reynard, Textbook of Pharmacology, 1991, p358) (See all compounds classified as Muscle Relaxants, Central.)
2-benzylbenzimidazole
Dibazole Use and Manufacturing
It can relax blood vessels, lower blood pressure, relieve smooth muscle spasm and stimulate the spinal cord. Used for hypertension, angina pectoris, toxemia of pregnancy, gastrointestinal spasm, sequelae of poliomyelitis, peripheral facial paralysis, etc.
Computed Properties
Molecular Weight:208.26
XLogP3:3.2
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:1
Rotatable Bond Count:2
Exact Mass:208.100048391
Monoisotopic Mass:208.100048391
Topological Polar Surface Area:28.7
Heavy Atom Count:16
Complexity:223
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Drug Function and Efficacy
Not yet clear
Recommended Suppliers of Dibazole
-
CN
5 YRS
Business licensedTrader Supplier of Intermediates,Building blocks,API,Silicones,Peptides,Lab chemicals,Biochemicals,Pharmaceuticals,Screening Compounds,Food Additives -
CN
2 YRS
Business licensedTrader Supplier of HPMC,Lithium Carbonate,Cellulose Acetate Tow,EVA resin,Terpene Resin,PP fiber,White Oil,LABSA,Sunflower oil,Carbon Black,Potassium Sorbate,Xanthan Gum,Neodymium Oxide,Tungsten Powder,Amfonelic Acid,Titanium DioxideInquiryCAS No.: 621-72-7Grade: Pharmaceutical GradeContent: 99.9% -
CN
4 YRS
Business licensedTrader Supplier of additives,pharmaceutical chemicals,organic intermediate,chemical intermediates,Pharmaceutical Intermediates,catalyst,API -
CN
5 YRS
Business licensedTrader Supplier of PVC resin,pvc paste resin,melamineInquiryCAS No.: 621-72-7Grade: Industrial GradeContent: 99% -
CN
3 YRS
Business licensedTrader Supplier of pharmaceutial intermediateInquiryCAS No.: 621-72-7Grade: Pharmaceutical GradeContent: 99%
Learn More Other Chemicals
-
Dronedarone
141626-36-0
-
Zofenopril calcium
81938-43-4
-
3-Bromo-1,3,4,5-tetrahydro-2H-1-benzazepin-2-one
86499-96-9
-
Tirofiban hydrochloride monohydrate Formula
150915-40-5
-
Saxagliptin Formula
361442-04-8
-
Dapoxetine Formula
119356-77-3
-
Fasudil Structure
103745-39-7
-
3,5-Pyridinedicarboxylic acid, 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-, 3-methyl 5-[(1-oxobutoxy)methyl] ester Structure
167221-71-8
-
What is 3-[(2R,5S)-5-(4-Fluorophenyl)-2-[(S)-[(4-fluorophenyl(amino)]][4-[trimethylsilyl]-oxy]phenyl]methyl]-1-oxo-5-[(trimethylsily)-oxy]pentyl]-4-phenyl-(4S)-2-oxazolidinone
272778-12-8
-
What is (-)-Oxyfedrine
15687-41-9